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Abstract Polyamine biosynthesis in mammalian cells
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Polyamines are highly regulated during cell
cycle progression
Normal c.ell rowth is orchestrated in a c.yc lie. ma.nner by the action
of cychns and cyc.i.irode.pendent kinases (cdks)9 and appropriate
activat.ion/ mac.tivati.on of these proteins is nec.e.ssary ftr ce.ll cycle
progrr.ssion. The. cychns A. B. D, and P. form complex.es with cor
rcponding dks and spcLih ills meul ttL thL (i IS md ( ‘M ph is
ot the cell cycle.. Sii.ssilariy. ODC and PA oncentrr.ti.on,. increase. Ifl
beth cell cycle phase.si°’ This strong positive relationship to cell
cycle re•gulation provides further evid.enc.e. that .PAs are intrinsis aID
hnke.d to cell growth. and prolife.ration2
Elevated polyamine levels can lead to cancer
.Rklevels are elevated, in many types of cancer, and interffi.rence with
p\ hiosynt.hesis has lonfi. been con.sidered a promisin.e therape.utic
mppro mh w unt proli’cr mu e eisa isa includine s ci ions m dign in
cies, w22 Eievated PA leve.ls ha.ve ab.o hee.n de.te.cted. in ui.ine.ofc.ar.cer
patients and can he mea.sured in blood and ce.re.hrospinal fluids.
ODC has hee.n k.nown ms a ma.rker of c.arcinoge.nesis a.nd tumor
progression and has he.en considered a protrooncogene.,’5wh.ich
is transac tivated. by cNIc, Ti.e ‘high enzymatic ac.iivit.iec. of ODE
nd AdoIatl)( in i ipidl) amos’ ing LOIS mud tissues md Lspe i
372
in tumor cells. rendered a rationale ‘br desiening pharrcleical
inhibitors. hich selectis els interlere with the natural bioss nihesic
of’ PAs and. consequentls, prevent tumor cell growth.
The clinically established polyamine inhibitors
DFMO and SAM486A
Overthe eource of more than 3Oyears. nanv researchers have focused
on the desien and sr nihesis at inhibitors, which interfere tb PA
metabolism. A large number of these synthetic inhibitor’ and
P-\ analocue were es aluated in i’iti’. in cell culture experiments.
and in am ma] cancer models, I—lowe \ er. so far, onl\ two PAinhihitors
have further advanced to the clinical setting, The most prominent
drug is the ODC inhibitor a-difluoromethylornithine (DFMO: also
known as Eliornithine) (Fig. I), which has been evaluated in Phase
II and ill cancer trials. The second dma is the AdoMetDC inhihi—
t()r 4-amidinoindan-l -one 2’-anidinohrdraionc S’\M156A: also
known as CGP4SÔ64A F’iw I . which was assessed in Phase I tri
als and inot recentl, in a Phase I multicenter study. Although
nionotnerap\ with DEMO has been disappointine in most cancer
trials, the drug was found more effectis e as achemopreventive agent
based on its low toxicit\. The reported side effects are relatively
mild with occasional occurrence of temporary ototoxicity, diarrhea,
and some neutropenia. Notably, DFM() is successfully used in the
treatment of a number of parasitic diseases, including the nice—
on with ]*vpanaoaocl brucci eaio?’icnse. w h ich causes A fri can
trvpanosonuasis. Recem Phase 11 clinical trials with SAM4SiA
in patients w itli relapsed or retraclorv non—F-lodgkin ‘s lvmphoina
were promisinc and the most frequent side effects included nausea,
vomiting, diarrhea, asthenia, abdominal pain, and l]ushing.
DFMO and SAM486A inhibit growth of human
neuroblastoma cells
Because DF\IO and S.\M4S6A are the only clinically es aluated
P—\ inhibitors with a relatively hich tolerance in patients, we has e
[ocusc-d our own research on these two drugs and arc studying their
effects on human neuroblastoma ( N B cells. .N B is an extra—cranial
tumor in infants and originates from prccursorcells of the peripheral
(sympathetic) nervous s stem and usually arises in a paraspinal
location in the abdomen or chest,3We thund that NB cells respond
more rapidl\ and more profoundly to the growth inhihitor effects
of DFvIO and SAM-itbA than. fbrexaniple. ox arian canccrcells or
otherecil inies discussed in the literature Fig. 2r To our knowledge.
N B trials w itli DFM() or S.A.’vi4Sb\ have not been conducted thus
‘er. and. ci sen the need t’br ness anti-neoplastic agents with nose]
inechanisnis of action, such trials should he seriously considered,
Our research further revealed that DFMO and SAM48&A are etiec
five aaanst NB cel.is with MYC.N amp.i.ifi.cation ttypicail.y derived
from more accre.ssi.ve N B tumors. which metastasize. and. do not
pond vs elI convent i lie! chemotherapy 1 and vs oh mutated tu mar
unpressar pmoten p) oPen loi,iid in relapsed ,cnd chemoresist,mt
NB tumors, thus further supportnv he ue 0 these druc far
tilerapeutlc N B t’eatments.
Prospective combination therapies for improved
efficacy in cancer trials
Al..thoughODC has generally been considered asthe cuzymecatalvz.
inn the rate limiting step in PA hioss itthecis, it has been shown that
the supply of dcAdoMet represents a second rate—limiting hictor in
PA bios\ nthesis.’’ and therefore, the enzr me AdoMetDC represents
a second rational target (Fig. H. Since the tss 0 enzymes are co—regu
lated by intracellular PA pools so that inhibition of one results in a
compensatory increase in the other, it follows that targeted interfer
ence with a drug cocktail composed of ODC inhibitor DEMO and
AdoMetDC inhibitor SAM4SbA I or other prospective PA inhibitors
of clinical mdcx ance is likely to sharpen the antiprolif’eratis e effects
by conuplete depletion of the PA pools. Such combination therapies
eoLild he further enhanced by the inclusion at retinoic acid r RAn a
ss ell-c[iaracteriied aaeitt that induces neuronal cell diftei’entiation
and is used in NB therapy. ‘ In addition, RA affects PA levels and
inhibits ODC activitv,iSi7Othus further contributing to the total
depletion of PA pools. Finally, the combination of the cytostatic
drug DFMO with SAM486A and some of the current cvtotoxic
drugs man pros ide a more posverful regimen amino N B and other
cancer tspes.
Conclusions
PAs are intrinsically connected to cell grosvth and proliferation, and
the inhibition of the sentinel PA biosynthetic enzymes ODC and
AdoMetDC is considered a means to prevent cell proliferation by
PA depletion. the blockade of cell cycle progression. and interfer
ence w ith signal ti’ansduetion. DEMO and SAM4Xfi.’\ have both
been cx aluated in htuiian cancer trials. hut so far, have only been
studied individual Is. Thus, further studies assessing the efficac of
combined drug’ therapies are certainly warranted. The treatment of
NB patients with a DFMO SAM4S6A cocktail, possibly in coni—
hinationi xvith RA and concontìitant with a PA—deficient diet should
he considered as an alternative protocol.
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F I V E WAYS Hit by a golf ball.
2. Run over by a golf cart.
TO D I E 0 N T H E Whacked by a golf club.
4. Struck by lightning.
GOLF COURSE: 5.Forgotyourhat,
Su..r i.ioinao, one rnthion .( OW cocos of shin CO4iCOS ars.i cietectssci evens yeas une persOn an Is our in the S. dies
from melanoma, the deadliest form of skis. cancer. If you spend a let of time ird the sun, you should protect ourse
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